The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $49.25

Today's change+0.68 +1.40%
Updated June 22 2:39 PM EDT. Delayed by at least 15 minutes.
 

Abbott Laboratories

NYSE: ABT
Last

(U.S.) $49.25

Today's change+0.68 +1.40%
Updated June 22 2:39 PM EDT. Delayed by at least 15 minutes.

Abbott Laboratories Hits New 100-day High

Abbott Laboratories is up today by (U.S.)$0.68 or 1.40% to (U.S.)$49.25 and setting a new 100-day high. Over the last five days, shares have gained 2.35% and 28.22% year to date. Shares have outperformed the S&P 500 by 10.17% during the last year.

Key company metrics

  • Open(U.S.) $48.60
  • Previous close(U.S.) $48.57
  • High(U.S.) $49.59
  • Low(U.S.) $48.51
  • Bid / Ask(U.S.) $49.24 / (U.S.) $49.25
  • YTD % change+28.22%
  • Volume5,069,758
  • Average volume (10-day)8,153,914
  • Average volume (1-month)6,911,413
  • Average volume (3-month)6,982,581
  • 52-week range(U.S.) $36.76 to (U.S.) $49.59
  • Beta1.58
  • Trailing P/E54.68×
  • P/E 1 year forward19.65×
  • Forward PEG1.75×
  • Indicated annual dividend(U.S.) $1.06
  • Dividend yield2.15%
  • Trailing EPS(U.S.) $0.90
Updated June 22 2:39 PM EDT. Delayed by at least 15 minutes.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue6,3355,3335,3025,333
Total other revenue--------
Total revenue6,3355,3335,3025,333
Gross profit3,2913,0233,0173,052
Total cost of revenue3,0442,3102,2852,281
Total operating expense6,5374,3854,4054,517
Selling / general / administrative2,2991,6061,6181,746
Research & development541338352348
Depreciation / amortization522121140145
Interest expense (income), net operating--------
Unusual expense (income)1311010-3
Other operating expenses, total--------
Operating income-202948897816
Interest income (expense), net non-operating-226-153-117-103
Gain (loss) on sale of assets--------
Other--------
Income before tax736875-179715
Income after tax386765-357599
Income tax, total350110178116
Net income419798-329615
Total adjustments to net income--------
Net income before extra. items386765-357599
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items386765-357599
Inc. avail. to common incl. extra. items419798-329615
Diluted net income419798-329615
Dilution adjustment----00
Diluted weighted average shares1,7351,4841,4761,480
Diluted EPS excluding extraordinary itemsvalue per share0.220.52-0.240.40
Dividends per sharevalue per share0.270.260.260.26
Diluted normalized EPSvalue per share0.260.52-0.240.40